IE55596B1 - Substituted diamino thiadiazoles - Google Patents

Substituted diamino thiadiazoles

Info

Publication number
IE55596B1
IE55596B1 IE686/83A IE68683A IE55596B1 IE 55596 B1 IE55596 B1 IE 55596B1 IE 686/83 A IE686/83 A IE 686/83A IE 68683 A IE68683 A IE 68683A IE 55596 B1 IE55596 B1 IE 55596B1
Authority
IE
Ireland
Prior art keywords
compound
pharmaceutically acceptable
hydrate
solvate
formula
Prior art date
Application number
IE686/83A
Other languages
English (en)
Other versions
IE830686L (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to IE705/88A priority Critical patent/IE55560B1/en
Publication of IE830686L publication Critical patent/IE830686L/xx
Publication of IE55596B1 publication Critical patent/IE55596B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE686/83A 1982-03-29 1983-03-28 Substituted diamino thiadiazoles IE55596B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE705/88A IE55560B1 (en) 1982-03-29 1983-03-28 Substituted diamino thiadiazole intermediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
IE830686L IE830686L (en) 1983-09-29
IE55596B1 true IE55596B1 (en) 1990-11-21

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
IE686/83A IE55596B1 (en) 1982-03-29 1983-03-28 Substituted diamino thiadiazoles

Country Status (30)

Country Link
JP (2) JPS58180477A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880002209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT386599B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU557577B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE896291A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH660880A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS250240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD219768A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3311281A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK166677B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8404683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2542741B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB2117769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU196386B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55596B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL68259A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1164633B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84716A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700942A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8301063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO163055C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ203726A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE461040B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU1419518A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA832154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW7683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
LU84716A1 (fr) 1983-12-05
AT386599B (de) 1988-09-12
GB2117769B (en) 1985-08-29
AU1290783A (en) 1983-10-06
ES527685A0 (es) 1985-06-16
SE8301725L (sv) 1983-11-25
ES527686A0 (es) 1985-06-16
NO163055B (no) 1989-12-18
GB2149406A (en) 1985-06-12
NO163055C (no) 1990-03-28
MY8700942A (en) 1987-12-31
GB2149406B (en) 1986-01-02
SE8704689D0 (sv) 1987-11-25
ES520982A0 (es) 1984-05-16
NO831100L (no) 1983-09-30
SU1355123A3 (ru) 1987-11-23
CS250240B2 (en) 1987-04-16
ES8505977A1 (es) 1985-06-16
IL68259A0 (en) 1983-06-15
AU557577B2 (en) 1986-12-24
KR840004095A (ko) 1984-10-06
GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-27
DD219768A5 (de) 1985-03-13
GB2117769A (en) 1983-10-19
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
NL8301063A (nl) 1983-10-17
DK81192A (da) 1992-06-18
OA07356A (fr) 1984-08-31
NZ203726A (en) 1986-05-09
HU188742B (en) 1986-05-28
ES8404683A1 (es) 1984-05-16
DE3311281A1 (de) 1983-11-24
IT1164633B (it) 1987-04-15
HU196386B (en) 1988-11-28
ES8505978A1 (es) 1985-06-16
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
SE461040B (sv) 1989-12-18
CH660880A5 (de) 1987-05-29
JPH06135925A (ja) 1994-05-17
DK81192D0 (da) 1992-06-18
FR2542741B1 (fr) 1989-12-08
GB8308518D0 (en) 1983-05-05
YU74483A (en) 1986-02-28
YU44849B (en) 1991-04-30
JPS58180477A (ja) 1983-10-21
IE830686L (en) 1983-09-29
SU1419518A3 (ru) 1988-08-23
PT76459A (en) 1983-04-01
DK141383D0 (da) 1983-03-28
PT76459B (en) 1986-03-11
BE896291A (fr) 1983-09-28
DD210909A5 (de) 1984-06-27
DK141383A (da) 1983-09-30
AU586037B2 (en) 1989-06-29
KR880002209B1 (ko) 1988-10-18
SE8301725D0 (sv) 1983-03-28
GB8432809D0 (en) 1985-02-06
ZW7683A1 (en) 1984-01-04
ZA832154B (en) 1983-12-28
ATA111083A (de) 1988-02-15
DK166677B1 (da) 1993-06-28
FR2597867B1 (fr) 1989-12-08
CS250229B2 (en) 1987-04-16
SE8704689L (sv) 1987-11-25
SE464302B (sv) 1991-04-08
JPH0568472B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-29
FR2542741A1 (fr) 1984-09-21

Similar Documents

Publication Publication Date Title
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
US4440933A (en) Process for preparing 1,2,5-thiadiazoles
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
IE55596B1 (en) Substituted diamino thiadiazoles
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
KR870000912B1 (ko) 디하이드로피리딘 유도체의 제조방법
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
US4526973A (en) Chemical compounds
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4595758A (en) Ethanediimidamide intermediates
US4503051A (en) Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
FI69069C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner
CA1253144A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h.sub.2-receptor antagonist activity
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
EP0452076A1 (en) Thiazole and imidazole derivatives and antiulcer composition containing same
NO880872L (no) Fremgangsmaate til fremstilling av en kjemisk forbindelse.
IE55560B1 (en) Substituted diamino thiadiazole intermediates
NZ213454A (en) Substituted ethandiimidamides
CY1448A (en) Chemical intermediates derived from cyclobutene
NZ193099A (en) N,n"-disubstituted-n1-(oxa(thia)azacycloalkylidene)guanidines

Legal Events

Date Code Title Description
MM4A Patent lapsed